President-elect Donald Trump's nominee for the Department of Health and Human Services, Robert F. Kennedy Jr., recently expressed his support for Trump's selection for Food and Drug Administration commissioner, Marty Makary, in a social media post over the weekend. Kennedy conveyed his enthusiasm to collaborate with Makary, a surgeon and researcher at Johns Hopkins University, who was appointed to the FDA position by Trump on Friday night.
In his post, Kennedy congratulated Makary on his nomination and highlighted his eagerness to work together to uphold the FDA's longstanding commitment to gold-standard, evidence-based science, eliminate corporate influence, and prioritize the nation's health and well-being.
It was noted that Kennedy played a significant role in assisting Trump in finalizing his choices for key public health positions, including the FDA commissioner and the director of the Centers for Disease Control.
These appointments have garnered attention from various public health experts who have expressed reservations about Trump's decision to nominate RFK Jr., known for his controversial views on vaccines, to a prominent health leadership role.
The unveiling of Trump's latest health appointees, announced amidst a flurry of Cabinet and staff updates on Friday night, offers insights into the potential direction of the agency under Kennedy's leadership, pending confirmation by the US Senate.
